Warning: The NCBI web site requires JavaScript to function. more...
Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.
Ghaemi A, Soleimanjahi H, Gill P, Hassan Z, Jahromi SR, Roohvand F.
Genet Vaccines Ther. 2010 May 12;8:3.
Related citations
In vivo gene delivery and expression by bacteriophage lambda vectors.
Lankes HA, Zanghi CN, Santos K, Capella C, Duke CM, Dewhurst S.
J Appl Microbiol. 2007 May;102(5):1337-49.
Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC.
Gene Ther. 2001 Jan;8(2):128-38.
Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
Lu Y, Zhang Z, Liu Q, Liu B, Song X, Wang M, Zhao X, Zhao Q.
Biol Pharm Bull. 2007 Jan;30(1):150-6.
Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70.
Zhou L, Zhu T, Ye X, Yang L, Wang B, Liang X, Lu L, Tsao YP, Chen SL, Li J, Xiao X.
Hum Gene Ther. 2010 Jan;21(1):109-19.
A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.
Lin CT, Tsai YC, He L, Calizo R, Chou HH, Chang TC, Soong YK, Hung CF, Lai CH.
J Biomed Sci. 2006 Jul;13(4):481-8. Epub 2006 Apr 29.
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.
Tseng CW, Trimble C, Zeng Q, Monie A, Alvarez RD, Huh WK, Hoory T, Wang MC, Hung CF, Wu TC.
Cancer Immunol Immunother. 2009 May;58(5):737-48. Epub 2008 Sep 25.
Genetic immunisation against hepatitis B using whole bacteriophage lambda particles.
March JB, Clark JR, Jepson CD.
Vaccine. 2004 Apr 16;22(13-14):1666-71.
SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model.
Sharma RK, Srivastava AK, Yolcu ES, MacLeod KJ, Schabowsky RH, Madireddi S, Shirwan H.
Vaccine. 2010 Aug 16;28(36):5794-802. Epub 2010 Jul 4.
Phage particle-mediated gene transfer of recombinant cosmids to cultured mammalian cells.
Ishiura M, Ohashi H, Uchida T, Okada Y.
Gene. 1989 Oct 30;82(2):281-9.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D.
Diniz MO, Lasaro MO, Ertl HC, Ferreira LC.
Clin Vaccine Immunol. 2010 Oct;17(10):1576-83. Epub 2010 Aug 25.
[Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):584-91. Chinese.
Proteasome inhibitors enhance bacteriophage lambda (lambda) mediated gene transfer in mammalian cells.
Volcy K, Dewhurst S.
Virology. 2009 Feb 5;384(1):77-87. Epub 2008 Dec 6.
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
J Virol. 2009 Jul;83(13):6779-89. Epub 2009 Apr 22.
Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.
Daemen T, Pries F, Bungener L, Kraak M, Regts J, Wilschut J.
Gene Ther. 2000 Nov;7(21):1859-66.
Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.
Chang EY, Chen CH, Ji H, Wang TL, Hung K, Lee BP, Huang AY, Kurman RJ, Pardoll DM, Wu T.
Int J Cancer. 2000 Jun 1;86(5):725-30.
Efficient expression of modified human papillomavirus 16 e6/e7 fusion protein and the antitumor efficacy in a mouse model.
Zhou X, Qian X, Zhao Q, Lu Y, Xiong M.
Biol Pharm Bull. 2004 Mar;27(3):303-7.
Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells.
Sapinoro R, Volcy K, Rodrigo WW, Schlesinger JJ, Dewhurst S.
Virology. 2008 Apr 10;373(2):274-86. Epub 2008 Jan 14.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on